Psilocybin and Compassion: A New Model for Treating Depression

When people read about psilocybin therapy in the news, the headlines tend to focus on the dramatic part. The mystical states. The breakthroughs. The trials showing rapid relief from depression after years of other treatments not quite working.

The headlines aren't wrong. The experiences can be that profound.

But there's a quieter question underneath, and it gets far less coverage.

What happens after?

Not the week after. The month, the season, the year. When the session has receded into memory and you're back inside your ordinary life with your ordinary mind, what actually carries forward?

What survives the experience

In my clinical work, the thing I watch most closely is the voice.

Someone comes back from a profound session with real insight. Real openness. A felt sense of having touched something that mattered. And then, over weeks, the same critical voice returns. Quieter at first. Then not quieter.

You're falling behind. You're not doing the work right. You should be further along by now. What's wrong with you that you can't make this stick?

That voice is not the depression, exactly. It's something more specific. It's the internalized harshness that many people carry as a kind of baseline. The relentless evaluation of every thought and feeling against a standard that was never reachable. The quiet conviction that something is fundamentally wrong with you.

For a lot of people, that voice isn't sitting on top of the depression. It's closer to the engine. The low mood and the withdrawal and the hopelessness are downstream of an inner relationship that turned adversarial years ago and never turned back.

Which raises an uncomfortable question about psychedelic work. If the medicine opens the system but the relationship inside it stays the same, what exactly has changed?

Someone put this question in writing

In 2022, two clinicians named Wendy Pots and Farid Chakhssi published a paper in Frontiers in Psychology arguing that psilocybin therapy for depression should be built inside a specific framework: Compassion Focused Therapy.

I want to be clear about what kind of paper this is, because it matters and it's easy to misread.

It's a proposal. The authors designed a treatment protocol, explained why they chose this framework over others, and sketched a study that could test it. As of publication, that study hadn't been run. They were still writing the manual for therapists.

So this isn't research showing the combination works. It's a group of experienced clinicians naming a real gap and putting a testable answer on the table. That's worth reading. It's just not the same thing as proof, and anyone presenting it as proof is getting ahead of the evidence.

The gap they name is this. In most psilocybin trials, the therapy wrapped around the dosing session gets described only by its shape. Preparation, session, integration. What actually happens inside those hours often goes unreported. Which leaves the field unable to answer something basic: what is the therapy contributing, and what kind of therapy contributes most?

Why compassion, specifically

Compassion Focused Therapy came out of an observation Paul Gilbert made working with chronically depressed clients who carried a lot of shame and self-criticism.

Those clients could do the cognitive work. They could challenge a thought, complete the worksheet, name the distortion. What they couldn't do was generate a self-compassionate inner voice.

You can correct a thought a thousand times. If the voice delivering the correction is still contemptuous, something essential hasn't moved.

Gilbert's model organizes emotion around three systems.

The threat system. Responds to danger with defense. Anxiety, anger, vigilance. In small doses it keeps you alive. Running constantly, it exhausts you.

The drive system. Achievement, resources, reward. Motivation and striving. In a lot of lives this one is hyperdeveloped.

The soothing system. Safety, connection, care. The capacity to calm and content yourself. This is the one that lets the nervous system actually rest.

In depression, the pattern the paper describes is threat and drive running hot while soothing stays underdeveloped. Sometimes severely. Some people have spent their whole lives without much soothing system activity at all. Driven, watchful, self-critical, and rarely warm with themselves.

Gilbert also uses a phrase I find enormously useful with clients: the tricky brain. The idea is that all of us arrived with an evolved brain and a set of formative circumstances we did not choose, and both of them shaped how we respond. The paper describes this concept as a way to de-shame people. It is not your fault that you have a brain capable of generating these states. It is not your fault that you were born into the circumstances that taught you these patterns.

That reframe alone does something in a room.

Why the authors think these two fit

Their argument is that psilocybin and CFT push in the same direction.

The paper cites research showing psilocybin increases feelings of connection and acceptance, and studies suggesting certain substances can produce increases in self-compassion and reductions in self-criticism similar to what compassion practices produce. People with depression tend to operate from the threat system. Deliver the medicine inside a framework built to activate the soothing system, and you may be doing something the medicine alone doesn't do.

There's evidence the medicine alone does a great deal. In a Johns Hopkins follow-up of 27 adults with long-standing depression, two doses of psilocybin with preparation and support produced large drops in depression that were still holding a year later. The researchers were careful to note this happened in a controlled research setting with substantial support from trained clinicians.

What nobody knows yet is how much of that durability comes from the therapy. The paper says so directly. It remains unclear if and how much therapeutic guidance is necessary. That's the open question at the center of all of this, and I'd rather sit with it honestly than pretend it's settled.

What the protocol actually asks of a person

Thirteen sessions across ten weeks. Two dosing days. Eleven therapy sessions.

That ratio is the part I keep returning to.

The preparation isn't a briefing. It's three sessions of learning the model, learning to breathe in a way that soothes rather than braces, and beginning to work with the different parts of yourself. By the third session you're setting an intention that came out of that work rather than out of nowhere.

The dosing sessions are largely non-directive. You're supported, not steered. The paper describes following the person's lead and trusting their own healing intelligence to determine what surfaces. When parts of the self come up, the therapist can guide you toward meeting them from the compassionate self rather than from the critic.

Then integration, which is most of the protocol. A debrief the day after. Weekly sessions that deepen the compassionate self and put it to work in ordinary life. Compassionate letter writing. Worksheets that address the inner critic directly. Practice, and more practice, and a final session that reviews what you've built and plans for the days it slips.

Two days of medicine. Eleven sessions of learning how to speak to yourself differently.

What's still open

The authors are candid, and I'd rather repeat their caution than smooth over it.

They don't know how much therapy is necessary. They also say plainly that other frameworks might work as well. Acceptance and Commitment Therapy has been proposed for the same purpose. CBT and Motivational Enhancement Therapy have been paired with psilocybin for other conditions. Their case for CFT is that it targets compassion and connection specifically, which may suit people high in shame and self-criticism. That's a reasonable hypothesis. Nobody has run the comparison.

Two more limits worth naming. The protocol was built for depression and the authors don't recommend generalizing it elsewhere. And it isn't meant for use with other psychedelics or medications.

The deeper shift

What stays with me here isn't a treatment recommendation. It's a change in what treatment is for.

Most mental health care is organized around symptom reduction. The score comes down. The subscale improves. Those things matter and I don't want to be glib about them.

This model is pointing at something else. It asks whether your default response to your own suffering is judgment or care, and treats that as the thing to change.

Many people have never really had the second one. They've been their own harshest critic so long that the harshness doesn't register as separate from who they are. It just feels like accuracy.

Whether psilocybin plus CFT turns out to be the best route there, I don't know. Neither does anyone else yet. But the premise underneath it holds regardless of how the trials come out: the relationship you have with yourself is not a fixed feature of who you are. It can be worked with directly. It can change.

For someone who has spent decades inside a punishing inner relationship, that possibility can be one of the more significant things they encounter.

Psilocybin may help open the door. The slow, unglamorous work of building self-compassion is what makes the room livable.